The crosstalk between EGFR and other growth factor receptors markedly enhances the progression of cancer by the transactivation of EGFR through interaction with platelet-derived growth factor (PDGFR) and IGF-1R [55,56,57]. This evidence concerns the gene PDGFRB and cancer.